The Quantellect read.As of Nov 19, 2026, 17 active firms cover Colgate-Palmolive Company: 11 rate it Buy or better, 6 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $87.00 to $110.00, so the covering firms are broadly aligned. The average target of $98.13 sits 1% below the current $98.84. The rating mix has stayed broadly stable, with Buy-side ratings easing from 13 to 11 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.97 next quarter toward $4.10 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS17 active firms
Buy
Strong Buy00%
Buy1165%
Neutral635%
Sell00%
Strong Sell00%
Based on 17 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$98.13
-0.7% downside
Average target across 15 active firms as of Nov 19, 2026 vs $98.84 current
Highest Target$110.00
Average Target$98.13
Lowest Target$87.00
Detailed analyst forecasts for CL
Showing 1–15 of 15 named analysts shown · 17 active firms in the rating projection
As of Nov 19, 2026, 11 of 17 active firms rate CL a Buy (6 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
CL EPS & revenue forecast
EPS · NEXT QUARTER
$0.97
Range $0.89 – $1.02 · 13 analysts · +0% YoY
Next period, 13 analysts expect Colgate-Palmolive Company to earn $0.97 a share (range $0.89 – $1.02), versus $0.97 a year earlier. Full-year consensus is $3.92, growing to $4.10 the year after.
REVENUE · NEXT QUARTER
$5.4B
Range $5.4B – $5.5B · 13 analysts · +2% YoY
Revenue is expected to reach $5.4B (range $5.4B – $5.5B), +2.1% year-over-year. Full-year consensus is $21.4B, rising to $21.9B next year.
Top analysts covering Colgate-Palmolive Company
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CL.
#1
Chris Carey
Wells Fargo · Rank #142
Neutral
$90.00-8.9% to target
Overall win rate
46%
+ Follow
#2
Andrea Teixeira
JP Morgan · Rank #146
Buy
$104.00+5.2% to target
Overall win rate
49%
+ Follow
#3
Michael Lavery
Piper Sandler · Rank #151
Buy
$95.00-3.9% to target
Overall win rate
47%
+ Follow
#4
Lauren Lieberman
Barclays · Rank #210
Neutral
$87.00-12.0% to target
Overall win rate
49%
+ Follow
#5
Peter Grom
UBS
Buy
$109.00+10.3% to target
Coverage
—
+ Follow
CL stock forecast FAQ
What is CL's average 12-month price target?+
The 15 active firms with a live target average $98.13 for Colgate-Palmolive Company over the next 12 months, ranging from a $110.00 high to a $87.00 low, as of Nov 19, 2026.
Is CL stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 17 active firms as of Nov 19, 2026, 11 rate it Buy or Strong Buy, 6 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for CL?+
The Street-high target is $110.00 (Citigroup), and the Street-low is $87.00 (Barclays). The average of all 15 active-firm targets is $98.13.
How many active Wall Street firms cover CL?+
17 active firms have a recognized rating on Colgate-Palmolive Company as of Nov 19, 2026, and 15 active firms carry a live 12-month price target.
Who is the most accurate analyst covering CL?+
Among analysts who currently cover CL, Chris Carey of Wells Fargo has the strongest overall Quantellect track record (Rank #142). Their current call is Neutral with a $90.00 target.
What is Colgate-Palmolive Company's projected EPS for next quarter?+
The consensus estimate is $0.97 per share (range $0.89 – $1.02) across 13 analysts. Full-year EPS is projected at $3.92, rising to $4.10 the following year.
How much revenue is Colgate-Palmolive Company expected to report next quarter?+
Consensus revenue is $5.4B (range $5.4B – $5.5B). Full-year revenue is projected at $21.4B, growing to $21.9B next year.
Have analysts been upgrading or downgrading CL lately?+
As of Nov 19, 2026, 11 of 17 active firms rate CL a Buy (6 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.